“…Nine articles described HrQoL among patients with the nomenclature of POI [36,39,40,42,47,49,[51][52][53] and ten articles described HrQoL among patients with the previous nomenclature of POF [37, 38, 41, 43-46, 48, 50, 54]. Thirteen articles had control groups [39-46, 48, 49, 51, 53, 54] and nine of these had a control group of women with normal ovarian function [41-46, 51, 53, 54], six of these had sufficient information to be included in the meta-analysis [41][42][43][44][45]54]. None of the studies used proxy-reports from family members as part of the evaluation.…”